CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced that it has underwritten the first annual G-Prize to celebrate and support innovation in synthetic biology. The inaugural G-Prize contest, conceived and exclusively sponsored by Gen9, was launched to foster creative and innovative approaches for using synthetic DNA constructs to advance industries including chemical and enzyme production, biofuels, pharmaceuticals, and even data storage.
